Vanhove Geertrui 4

4 · Surrozen, Inc./DE · Filed Oct 13, 2022

Form 4

Period: 2022-10-10

Chief Medical Officer

Transactions

Disposition to Issuer
Option (right to buy)
2022-10-10−1,760→ 0 total
Exercise: $10.77From: 2021-02-01Exp: 2031-02-22→ Common Stock (1,760 underlying)
Award
Option (right to buy)
2022-10-10+26,220→ 26,220 total
Exercise: $2.16From: 2022-08-12Exp: 2031-08-12→ Common Stock (26,220 underlying)
Award
Option (right to buy)
2022-10-10+1,760→ 1,760 total
Exercise: $2.16From: 2021-02-01Exp: 2031-02-22→ Common Stock (1,760 underlying)
Disposition to Issuer
Option (right to buy)
2022-10-10−24,587→ 0 total
Exercise: $10.77From: 2021-02-01Exp: 2031-02-22→ Common Stock (24,587 underlying)
Disposition to Issuer
Option (right to buy)
2022-10-10−10,427→ 0 total
Exercise: $10.25From: 2022-08-12Exp: 2031-08-12→ Common Stock (10,427 underlying)
Award
Option (right to buy)
2022-10-10+24,587→ 24,587 total
Exercise: $2.16From: 2021-02-01Exp: 2031-02-22→ Common Stock (24,587 underlying)
Disposition to Issuer
Option (right to buy)
2022-10-10−26,220→ 0 total
Exercise: $10.25From: 2022-08-12Exp: 2031-08-12→ Common Stock (26,220 underlying)
Award
Option (right to buy)
2022-10-10+10,427→ 10,427 total
Exercise: $2.16From: 2022-08-12Exp: 2031-08-12→ Common Stock (10,427 underlying)

Footnotes (4)

[F1]The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price.
[F2]The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date.
[F3]The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price.
[F4]Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Documents

1 file